Excess Medical Spending Reaches Nearly $7 Billion in a Year
Published Online: Friday, October 7th, 2011
Kate H. Gamble, Senior Editor
Kate H. Gamble, Senior Editor
Researchers at Mount Sinai School of Medicine have found that $6.7 billion was spent in 1 year performing unnecessary tests or prescribing unnecessary medications in primary care, with 86% of the cost attributed to the prescription of brand-name statins to treat hypercholesterolemia, according to findings published in the Archives of Internal Medicine.
Led by Minal Kale, MD, the research team reviewed findings from a study published in the May 2011 issue of Archives of Internal Medicine, which identified the top five most overused clinical activities in each of three primary care specialties: pediatrics, internal medicine, and family medicine. With this information, they performed a cross-sectional analysis of separate data that were pulled from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. The authors found that there was more than $6.7 billion in excess healthcare spending in the primary care setting in 2009, with more than $5.8 billion (86%) of the unnecessary spending resulting from the prescribing of brand-name statins rather than generic versions.
“Our analysis shows astronomical costs associated with prescribing of brand name statins when effective, generic alternatives were available. Efforts to encourage prescribing of generics clearly have not gone far enough,” said Dr. Kale in a statement. “Additionally, millions are spent on unnecessary blood work, scans, and antibiotic prescriptions. Significant efforts to reduce this spending are required in order to stem these exorbitant activities.”
The remaining costs were attributable to the following:
The authors noted that the analysis is limited to the data provided by the surveys, and that they were conservative in their assessments. They concluded that this type of analysis should be extended to medical specialties outside of primary care and that physicians should make efforts in their own practices to evaluate costs and reduce them where necessary in order to achieve affordable, high-quality care.
Led by Minal Kale, MD, the research team reviewed findings from a study published in the May 2011 issue of Archives of Internal Medicine, which identified the top five most overused clinical activities in each of three primary care specialties: pediatrics, internal medicine, and family medicine. With this information, they performed a cross-sectional analysis of separate data that were pulled from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. The authors found that there was more than $6.7 billion in excess healthcare spending in the primary care setting in 2009, with more than $5.8 billion (86%) of the unnecessary spending resulting from the prescribing of brand-name statins rather than generic versions.
“Our analysis shows astronomical costs associated with prescribing of brand name statins when effective, generic alternatives were available. Efforts to encourage prescribing of generics clearly have not gone far enough,” said Dr. Kale in a statement. “Additionally, millions are spent on unnecessary blood work, scans, and antibiotic prescriptions. Significant efforts to reduce this spending are required in order to stem these exorbitant activities.”
The remaining costs were attributable to the following:
- During physical exams, more than half of complete blood work ordered was not needed, resulting in more than $32 million in excess costs;
- Unnecessary bone density scans in younger women accounted for more than $527 million;
- CT scans, MRIs, or X-Rays in people presenting with back pain accounted for $175 million in excess healthcare costs;
- Over-prescription of antibiotics for sore throat in children, excluding cases of strep throat or fever, accounted for $116 million in unnecessary costs;
- Other excess costs included needless annual echocardiograms, urine testing, pap tests, and pediatric cough medicine prescriptions.
The authors noted that the analysis is limited to the data provided by the surveys, and that they were conservative in their assessments. They concluded that this type of analysis should be extended to medical specialties outside of primary care and that physicians should make efforts in their own practices to evaluate costs and reduce them where necessary in order to achieve affordable, high-quality care.
Your comments are valuable to us. Thank you.

American Journal of Managed Care
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
PainLive
Pharmacy Times
Physician's Money Digest
American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
PainLive
Pharmacy Times
Physician's Money Digest
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.




Email
Print


